Browsing Tag
AB-101
1 post
How AlloNK could challenge autologous CAR-T approaches in difficult autoimmune diseases
Can AlloNK challenge autoimmune CAR-T therapies? Explore what Artiva Biotherapeutics, Inc.’s latest data means for the future of cell therapy.